BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18097609)

  • 1. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.
    Siebolts U; Thiele J; Zander T; Ditschkowski M; Beelen DW; Kröger N; Fehse B; Wickenhauser C
    Oncol Rep; 2008 Jan; 19(1):287-92. PubMed ID: 18097609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FISH analysis of native smears from bone marrow and blood for the monitoring of chimerism and clonal markers after stem cell transplantation in children.
    Fuehrer M; Gerusel-Bleck M; Konstantopoulos N; Bender-Goetze C; Walther JU
    Int J Mol Med; 2005 Feb; 15(2):291-7. PubMed ID: 15647846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow and peripheral stem cell transplantation from a haplo-identical mother and CD34 positive selection for CML.
    Kato K; Kojima S; Kondo M; Inaba J; Matsuyama T
    Bone Marrow Transplant; 1996 Aug; 18(2):449-52. PubMed ID: 8864462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantation.
    Thiele J; Varus E; Siebolts U; Kvasnicka HM; Wickenhauser C; Metz KA; Beelen DW; Ditschkowski M; Zander A; Kröger N
    Histol Histopathol; 2007 Apr; 22(4):365-72. PubMed ID: 17290346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia.
    Xu LP; Luo XH; Chang YJ; Liu DH; Liu KY; Chen YH; Huang XJ
    Ann Hematol; 2009 Oct; 88(10):1015-24. PubMed ID: 19319533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia.
    Kronenwett R; Butterweck U; Steidl U; Kliszewski S; Neumann F; Bork S; Blanco ED; Roes N; Gräf T; Brors B; Eils R; Maercker C; Kobbe G; Gattermann N; Haas R
    Oncogene; 2005 Aug; 24(34):5313-24. PubMed ID: 15806158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of bone marrow fibrosis and stromal antigenic expression in chronic myeloid leukemia on alpha interferon and Ara-C therapy.
    Straetmans N; Ma DD; Nevell DF; Arthur C
    Hematopathol Mol Hematol; 1996; 10(4):213-22. PubMed ID: 9042664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Santucci MA; Trabetti E; Martinelli G; Buzzi M; Zaccaria A; Pileri S; Farabegoli P; Sabattini E; Tura S; Pignatti PF
    Bone Marrow Transplant; 1992 Sep; 10(3):255-9. PubMed ID: 1422479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of CD34+ progenitor cells following allogeneic bone marrow transplantation in Ph1+CML--an immunohistochemical study on 113 patients with sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Beelen DW; Cicek G; Leder LD; Schaefer UW
    J Hematother Stem Cell Res; 2002 Jun; 11(3):565-74. PubMed ID: 12183841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis.
    Ni H; Barosi G; Rondelli D; Hoffman R
    Am J Clin Pathol; 2005 Jun; 123(6):833-9. PubMed ID: 15899773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple unrelated clonal abnormalities in host bone marrow cells after allogeneic stem cell transplantation.
    Kebriaei P; Winter JN; Laport GG; Le Beau MM; Dewald G; Larson RA
    Leuk Res; 2004 May; 28(5):537-40. PubMed ID: 15068908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Zirbes TK; Jung F; Reske D; Leder LD; Schaefer UW
    Bone Marrow Transplant; 2000 Aug; 26(3):275-81. PubMed ID: 10967565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed chimerism of bone marrow vessels (endothelial cells, myofibroblasts) following allogeneic transplantation for chronic myelogenous leukemia.
    Kvasnicka HM; Wickenhauser C; Thiele J; Varus E; Hamm K; Beelen DW; Schaefer UW
    Leuk Lymphoma; 2003 Feb; 44(2):321-8. PubMed ID: 12688352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplantation.
    Thiele J; Wickenhauser C; Kvasnicka HM; Varus E; Schneider C; Müller H; Beelen DW
    Acta Haematol; 2003; 109(4):176-83. PubMed ID: 12853689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitated engraftment by intramedullary administered enriched allogeneic CD34+ cells?
    Yano M; Watanabe A; Kawano Y; Watanabe T; Takaue Y
    Bone Marrow Transplant; 1999 Apr; 23(8):847-8. PubMed ID: 10231152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.